Sir, I have just one question. Given the recent U.S. court ruling allowing MSN Pharma early entry into this drug, Entresto, could you quantify the anticipated revenue impact for FY26?
Got it. Sure, ma’am. Thank you.
Questions across 1 call
Mohit Jain
DR Choksey Finserv Private Limited